Key Points Net loss attributable to common stockholders totaled $20.7 million for the three months ended June 30, 2025. Net loss attributable to common stockholders was $20.7 million for the three ...

Despite not coming from a healthcare background, Yaccarino brings over a decade of experience in digital revenue and brand ...

Discover how weight loss medications and smart nutrition can silence cravings in Food Noise by Dr. Jack Mosley.

The drugmaker released its second-quarter earnings report early Wednesday as it vowed to cut costs amid intensifying ...

Novo Nordisk has abandoned another GLP-1/GIP co-agonist and CB1 receptor as part of a significant pipeline clearout that ...

Novo Nordisk cautioned on Wednesday that it expects continued competition this year from copycat versions of its Wegovy ...